Abstract:Neurodegenerative illnesses (NDDs) like Alzheimer's, Parkinson's, amyotrophic lateral sclerosis, spinal muscular atrophy, and Huntington's disease have demonstrated considerable potential for gene therapy as a viable therapeutic intervention. NDDs are marked by the decline of neurons, resulting in changes in both behavior and pathology within the body. Strikingly, only symptomatic management is available without a cure for the NDDs. There is an unmet need for a permanent therapeutic approach. Many studies have been going on to target the newer therapeutic molecular targets for NDDs including gene-based therapy. Gene therapy has the potential to provide therapeutic benefits to a large number of patients with NDDs by offering mechanisms including neuroprotection, neuro-restoration, and rectification of pathogenic pathways. Gene therapy is a medical approach that aims to modify the biological characteristics of living cells by controlling the expression of specific genes in certain neurological disorders. Despite being the most complex and well-protected organ in the human body, there is clinical evidence to show that it is possible to specifically target the central nervous system (CNS). This provides hope for the prospective application of gene therapy in treating NDDs in the future. There are several advanced techniques available for using viral or non-viral vectors to deliver the therapeutic gene to the afflicted region. Neurotrophic factors (NTF) in the brain are crucial for the development, differentiation, and survival of neurons in the CNS, making them important in the context of various neurological illnesses. Gene delivery of NTF has the potential to be used as a therapeutic approach for the treatment of neurological problems in the brain. This review primarily focuses on the methodologies employed for delivering the genes of different NTFs to treat neurological disorders. These techniques are currently being explored as a viable therapeutic approach for neurodegenerative diseases. The article exclusively addresses gene delivery approaches and does not cover additional therapy strategies for NDDs. Gene therapy offers a promising alternative treatment for NDDs by stimulating neuronal growth instead of solely relying on symptom relief from drugs and their associated adverse effects. It can serve as a long-lasting and advantageous treatment choice for the management of NDDs. The likelihood of developing NDDs increases with age as a result of neuronal degradation in the brain. Gene therapy is an optimal approach for promoting neuronal growth through the introduction of nerve growth factor genes.

Recovery characteristics of fault current limiter with adjustable trigger current level

A survey of caretakers in adult foster homes.

Novel Gene Therapy Approaches for Targeting Neurodegenerative Disorders: Focusing on Delivering Neurotrophic Genes

Advanced molecular therapies for neurological diseases: focus on stroke, alzheimer's disease, and parkinson's disease

Current Knowledge and Therapeutic Implications

Neurodegenerative disorders: Mechanisms of degeneration and therapeutic approaches with their clinical relevance

Neuroinflammation: A Critical Factor in Neurodegenerative Disorders

The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets

The osteocyte as a therapeutic target in the treatment of osteoporosis

Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond

Recent Research Trends in Neuroinflammatory and Neurodegenerative Disorders

Insights into the advances in therapeutic drugs for neuroinflammation-related diseases

The Neuro-Inflammatory Microenvironment: an Important Regulator of Stem Cell Survival in Alzheimer’s Disease

Genetic Risk, Inflammation, and Therapeutics: An Editorial Overview of Recent Advances in Aging Brains and Neurodegeneration

Gene Therapy for Neurodegenerative Disorders: Advances, Insights and Prospects

Nanoparticle-based Gene Therapy for Neurodegenerative Disorders

Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer’s disease

Gene therapy for CNS disorders: modalities, delivery and translational challenges

From Lab Bench to Hope: Emerging Gene Therapies in Clinical Trials for Alzheimer's Disease

JAK2/STAT3 as a new potential target to manage neurodegenerative diseases: An interactive review

Management of Neuroinflammatory Responses to AAV-Mediated Gene Therapies for Neurodegenerative Diseases